News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis
Photo taken from Lea Monteran/X
Mar 8, 2024, 19:03

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter:

“I am excited to share our latest work (and Ph.D.’s baby) with Neta Erez on breast cancer bone metastasis, showing how combining TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis. In Cancer Discovery.”

Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis

Proceed to the article.
Source: Lea Monteran/X

bone metastases Breast Cancer cancer Cancer Discovery Lea Monteran MDSC inhibition metastatic breast cancer Neta Erez OncoDaily Oncology Tel Aviv University TIGIT blockade
Special Coverage
Blog
Apr 22, 2025, 17:31
Vivek Subbiah: It's moments like these that remind me why I do what I do
Positive
Apr 22, 2025, 17:21
Foundation S marks 20 years of impact through My Child Matters - Childhood Cancer International
Blog
Apr 22, 2025, 17:11
Lisa A. Lacasse: We’re able to elevate the patient voice in the fight against cancer at every level of government
Blog
Apr 22, 2025, 17:05
Paul Ekert presents ZERO program at St. Jude Symposium - Children's Cancer Institute
Blog
Apr 22, 2025, 16:58
Wafik S. El-Deiry: Best Practices for Sponsored Research event
Opinion
Apr 22, 2025, 16:42
Nathan Pennell: The Medical community needs to oppose the Department of Justice's threats to journal independence
Blog
Apr 22, 2025, 16:28
Ruben Mesa: Celebrating the extraordinary 27 year tenure of Bayard Powell as the Chief of Hematology and Medical Oncology
Career
Apr 22, 2025, 16:21
Five MD Anderson researchers were honored with 2025 AACR Scientific Achievement Awards
Blog
Apr 22, 2025, 15:38
Nicholas DeVito Highlights Enrollment for BBOpCo Immunotherapy Trial
Drugs
Apr 22, 2025, 15:25
Binimetinib (Mektovi): Uses in Cancer, Side effects, Dosage, Expectations, and more
Blog
Apr 22, 2025, 15:02
Ammira Al-Shabeeb Seeks Bioinformatics Scientist for Genomic Medicine Team
Dialogues
Apr 22, 2025, 14:36
Inside the Biotech Frontier: Chris Burns on Amplia’s Vision and Cancer Drug Development